220 related articles for article (PubMed ID: 10730913)
1. Therapeutic potential of terbinafine in subcutaneous and systemic mycoses.
Hay RJ
Br J Dermatol; 1999 Nov; 141 Suppl 56():36-40. PubMed ID: 10730913
[TBL] [Abstract][Full Text] [Related]
2. Terbinafine: broad new spectrum of indications in several subcutaneous and systemic and parasitic diseases.
Pérez A
Mycoses; 1999; 42 Suppl 2():111-4. PubMed ID: 10865916
[TBL] [Abstract][Full Text] [Related]
3. Treatment of cutaneous sporotrichosis with terbinafine.
Hull PR; Vismer HF
Br J Dermatol; 1992 Feb; 126 Suppl 39():51-5. PubMed ID: 1543674
[TBL] [Abstract][Full Text] [Related]
4. Subcutaneous fungal infections.
Pang KR; Wu JJ; Huang DB; Tyring SK
Dermatol Ther; 2004; 17(6):523-31. PubMed ID: 15571502
[TBL] [Abstract][Full Text] [Related]
5. Terbinafine: broad new spectrum of indications in several subcutaneous and systemic and parasitic diseases.
Pérez A
Mycoses; 1999 Dec; 42 Suppl 2():111-114. PubMed ID: 29265609
[TBL] [Abstract][Full Text] [Related]
6. Terbinafine. An update of its use in superficial mycoses.
McClellan KJ; Wiseman LR; Markham A
Drugs; 1999 Jul; 58(1):179-202. PubMed ID: 10439936
[TBL] [Abstract][Full Text] [Related]
7. Use of terbinafine in rare and refractory mycoses.
Revankar SG; Nailor MD; Sobel JD
Future Microbiol; 2008 Feb; 3(1):9-17. PubMed ID: 18230029
[TBL] [Abstract][Full Text] [Related]
8. Subcutaneous mycoses.
Queiroz-Telles F; McGinnis MR; Salkin I; Graybill JR
Infect Dis Clin North Am; 2003 Mar; 17(1):59-85, viii. PubMed ID: 12751261
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic approaches to subcutaneous mycoses.
Koga T; Matsuda T; Matsumoto T; Furue M
Am J Clin Dermatol; 2003; 4(8):537-43. PubMed ID: 12862496
[TBL] [Abstract][Full Text] [Related]
10. [New antifungal agents in the treatment of superficial dermatomycoses].
Degreef H
Ann Dermatol Venereol; 1993; 120(1):21-31. PubMed ID: 8393313
[TBL] [Abstract][Full Text] [Related]
11. Tropical mycoses.
Bayles MA
Chemotherapy; 1992; 38 Suppl 1():27-34. PubMed ID: 1319312
[TBL] [Abstract][Full Text] [Related]
12. Oral itraconazole therapy for superficial, subcutaneous, and systemic infections. A panoramic view.
De Rosso JQ; Gupta AK
Postgrad Med; 1999 Jul; Spec No():46-52. PubMed ID: 10492666
[TBL] [Abstract][Full Text] [Related]
13. Subcutaneous mycoses in coastal Karnataka in south India.
Bhat RM; Monteiro RC; Bala N; Dandakeri S; Martis J; Kamath GH; Kambil SM; Asha Vadakayil R
Int J Dermatol; 2016 Jan; 55(1):70-8. PubMed ID: 26267755
[TBL] [Abstract][Full Text] [Related]
14. [Tropical mycoses].
Bayles MA
Med Klin (Munich); 1991 Dec; 86 Suppl 1():13-9. PubMed ID: 1663201
[TBL] [Abstract][Full Text] [Related]
15. Coccidioidomycosis and other endemic mycoses in Mexico.
Laniado-Laborín R
Rev Iberoam Micol; 2007 Dec; 24(4):249-58. PubMed ID: 18095755
[TBL] [Abstract][Full Text] [Related]
16. Terbinafine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in superficial mycoses.
Balfour JA; Faulds D
Drugs; 1992 Feb; 43(2):259-84. PubMed ID: 1372222
[TBL] [Abstract][Full Text] [Related]
17. Antifungal activity of itraconazole and terbinafine in human stratum corneum: a comparative study.
Piérard GE; Arrese JE; De Doncker P
J Am Acad Dermatol; 1995 Mar; 32(3):429-35. PubMed ID: 7868711
[TBL] [Abstract][Full Text] [Related]
18. Deep fungal infections in tropical countries.
Rivitti EA; Aoki V
Clin Dermatol; 1999; 17(2):171-90; discussion 105-6. PubMed ID: 10330600
[No Abstract] [Full Text] [Related]
19. New antifungal agents.
Lesher JL
Dermatol Clin; 1992 Oct; 10(4):799-805. PubMed ID: 1327600
[TBL] [Abstract][Full Text] [Related]
20. [Experimental cutaneous sporotrichosis: in vivo evaluation of itraconazole and terbinafine].
Antunes Tde A; Nobre Mde O; Faria RO; Meinerz AR; Martins AA; Cleff MB; Fernandes CG; Meireles MC
Rev Soc Bras Med Trop; 2009; 42(6):706-10. PubMed ID: 20209359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]